Name: Neutrophil Gelatinaseassociated Lipocalin: From Laboratory to Clinical Utility (Renal and Urologic Disorders) (en Inglés)
Price: 212.20 USD
Availability: InStock
Author: Mina Hur
ISBN: 9781631179846

portada Neutrophil Gelatinaseassociated Lipocalin: From Laboratory to Clinical Utility (Renal and Urologic Disorders) (en Inglés)

Neutrophil Gelatinaseassociated Lipocalin: From Laboratory to Clinical Utility (Renal and Urologic Disorders) (en Inglés)

Formato

Libro Físico

Autor

Mina Hur

Categoría

Libros de Textos

Año

2014

Idioma

Inglés

N° páginas

144

Encuadernación

Tapa Dura

ISBN13

9781631179846

N° edición

Neutrophil Gelatinaseassociated Lipocalin: From Laboratory to Clinical Utility (Renal and Urologic Disorders) (en Inglés)

Mina Hur (Autor) · · Tapa Dura

Libro Nuevo Importado

Envío: 15 a 22 días háb.

$ 385.82$ 212.20

-45%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 2 unidades

$ 212.20

Llega entre el 18 Ago y el 31 Ago a Quito, Pichincha. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Neutrophil Gelatinaseassociated Lipocalin: From Laboratory to Clinical Utility (Renal and Urologic Disorders) (en Inglés)"

Acute kidney injury (AKI), defined as an abrupt decrease in renal function over a period of hours to days, is a common complication among hospitalised patients with different acute diseases. Its incidence has been increasing in recent years and is reported to be very high especially in the acute settings. Since clinical signs and symptoms of acute renal damage are not specific, it is difficult to promptly distinguish AKI at the time of patient presentation. Currently the diagnosis of AKI requires serial assessment of laboratory tests over a period of several days, and is based mainly on the evaluation of serum creatinine (sCr) and decrease in urine output as supported by Risk, Injury, Failure, Loss, and End-Stage Kidney Disease (RIFLE) criteria, Acute Kidney Injury Network (AKIN) criteria, and the recent Kidney Disease: Improving Global Outcomes (KDIGO) practice guidelines for AKI. Such a need for repeated sCr evaluations and monitoring of urinary output for too long time after admission could therefore result in a diagnostic delay. With delays in diagnosis, clinicians miss opportunities to start appropriate treatment to minimise damage, and patients incur more severe AKI with subsequent greater risk of developing progression of renal damage leading to chronic kidney disease (CKD), dialysis and increased risk of severe cardiovascular diseases and death.